- Home
- NNNN vs NAN Comparison
NNNN vs NAN Comparison
Compare NNNN & NAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- NAN
- Stock Information
- Founded
- NNNN 2021
- NAN 1999
- Country
- NNNN Germany
- NAN United States
- Employees
- NNNN N/A
- NAN N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NAN Investment Managers
- Sector
- NNNN Health Care
- NAN Finance
- Exchange
- NNNN Nasdaq
- NAN Nasdaq
- Market Cap
- NNNN 369.6M
- NAN 349.4M
- IPO Year
- NNNN 2025
- NAN N/A
- Fundamental
- Price
- NNNN $49.26
- NAN $11.44
- Analyst Decision
- NNNN
- NAN
- Analyst Count
- NNNN 0
- NAN 0
- Target Price
- NNNN N/A
- NAN N/A
- AVG Volume (30 Days)
- NNNN 220.1K
- NAN 74.6K
- Earning Date
- NNNN 01-01-0001
- NAN 01-01-0001
- Dividend Yield
- NNNN N/A
- NAN 4.37%
- EPS Growth
- NNNN N/A
- NAN N/A
- EPS
- NNNN 0.06
- NAN N/A
- Revenue
- NNNN $8,185,146.00
- NAN N/A
- Revenue This Year
- NNNN N/A
- NAN N/A
- Revenue Next Year
- NNNN N/A
- NAN N/A
- P/E Ratio
- NNNN $908.77
- NAN N/A
- Revenue Growth
- NNNN 21.95
- NAN N/A
- 52 Week Low
- NNNN $5.18
- NAN $9.11
- 52 Week High
- NNNN $53.11
- NAN $11.34
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- NAN 58.05
- Support Level
- NNNN N/A
- NAN $11.34
- Resistance Level
- NNNN N/A
- NAN $11.48
- Average True Range (ATR)
- NNNN 0.00
- NAN 0.07
- MACD
- NNNN 0.00
- NAN 0.01
- Stochastic Oscillator
- NNNN 0.00
- NAN 66.00
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About NAN Nuveen New York Quality Municipal Income Fund
Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal, New York State and New York City income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.